---

Medical Advocates Ethics and Infectious Diseases
		Ethical Challenges Screening/Testing Refusal of Care/Services Detention Patient Exploitation Compulsory Treatment Decision-Making Reproduction Transplants End-of-Life Care Enteral Nutrition Professional Associations National Challenges         Sterilization Bioterrorism                     Prison Challenges HIV Exceptionalism           Conflicts of Interest Pharmaceutical Industry   Pregnancy HIV Prevention    Stigma Physician Reimbursement  Ethics and Disease Challenges and Duties HIV Cure Ebola Virus Disease Executions

---

Ethics Main Page

Main New and Noteworthy

Home Page

---

Medical Advocates Efavirenz (Sustiva/Strocrin)   Main Page New and Noteworthy Atripla Database of ARV Drug Interactions Journal Data Conference Data Guidelines Perinatal Data Pediatric Data ARV Drugs Main Page ARV Drugs Main Page Main New/Newsworthy  Home Page       This web page is best viewed by using INTERNET EXPLORER Last Update:  April 24, 2018  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader New and Noteworthy April 2018 FULL-TEXT ARTICLE Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial. Turkova A, Moore CL, Butler K et al  PLoS One. 2018 Apr 23;13(4):e0196239